Terakedis BE - Search Results

1

Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma.

Cannon GM, Geye H, Terakedis BE, Kushner DM, Connor JP, Hartenbach EM, Bradley KA. Cannon GM, et al. Among authors: terakedis be. Gynecol Oncol. 2009 May;113(2):176-80. doi: 10.1016/j.ygyno.2008.12.029. Epub 2009 Feb 12. Gynecol Oncol. 2009. PMID: 19217147

2

Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.

Chen LA, Kim J, Boucher K, Terakedis B, Williams B, Nickman NA, Gaffney DK. Chen LA, et al. Gynecol Oncol. 2015 Mar;136(3):521-8. doi: 10.1016/j.ygyno.2014.12.039. Epub 2015 Jan 3. Gynecol Oncol. 2015. PMID: 25562668

3

A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.

Terakedis BE, Rossi PJ, Liauw SL, Johnstone PA, Jani AB. Terakedis BE, et al. Am J Clin Oncol. 2010 Dec;33(6):619-23. doi: 10.1097/COC.0b013e3181c4c6e1. Am J Clin Oncol. 2010. PMID: 20051808

4

The Prognostic Significance of Facial Nerve Involvement in Carcinomas of the Parotid Gland.

Terakedis BE, Hunt JP, Buchmann LO, Avizonis VN, Anker CJ, Hitchcock YJ. Terakedis BE, et al. Am J Clin Oncol. 2017 Jun;40(3):323-328. doi: 10.1097/COC.0000000000000157. Am J Clin Oncol. 2017. PMID: 25503431

5

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.

Terakedis B, Sause W. Terakedis B, et al. Front Oncol. 2011 Nov 30;1:47. doi: 10.3389/fonc.2011.00047. eCollection 2011. Front Oncol. 2011. PMID: 22645713 Free PMC article.

6

Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.

Terakedis BE, Anker CJ, Leachman SA, Andtbacka RH, Bowen GM, Sause WT, Grossmann KF, Bowles TL, Noyes RD, Hitchcock YJ, Boucher KM, Shrieve DC. Terakedis BE, et al. J Am Acad Dermatol. 2014 Mar;70(3):435-42. doi: 10.1016/j.jaad.2013.10.028. Epub 2013 Dec 24. J Am Acad Dermatol. 2014. PMID: 24373782

7

Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases.

Terakedis BE, Jensen RL, Boucher K, Shrieve DC. Terakedis BE, et al. J Radiosurg SBRT. 2014;3(1):21-28. J Radiosurg SBRT. 2014. PMID: 29296381 Free PMC article.

8

An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo.

De P, Dey N, Terakedis B, Bergsagel PL, Li ZH, Mahadevan D, Garlich JR, Trudel S, Makale MT, Durden DL. De P, et al. Cancer Chemother Pharmacol. 2013 Apr;71(4):867-81. doi: 10.1007/s00280-013-2078-0. Epub 2013 Jan 25. Cancer Chemother Pharmacol. 2013. PMID: 23355037 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters